Curaleaf Holdings (CURLF) Retained Earnings (2019 - 2025)
Curaleaf Holdings (CURLF) recorded quarterly Retained Earnings of -$1.8 million in Q4 2025, up 99.87% quarter-over-quarter from -$1.4 billion in Q4 2024, and up 99.87% on a YoY basis from -$904603.0 in Q4 2024.
Curaleaf Holdings (CURLF) Retained Earnings (2019 - 2025) Analysis & Trends
Curaleaf Holdings' Retained Earnings history runs 7 years deep, the most recent figure standing at -$1.8 million for Q4 2025.
- In Q4 2025, Retained Earnings rose 99.87% year-over-year to -$1.8 million; the TTM figure through Dec 2025 stood at -$1.8 million (up 99.87% YoY), while the FY2025 annual figure was -$1.8 million, up 99.87% from the prior year.
- Retained Earnings was -$1.8 million for Q4 2025 at Curaleaf Holdings, up from -$1.4 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$1.8 million in Q4 2025 to a low of -$311.4 billion in Q1 2022.
- Historically, Retained Earnings has averaged -$21.3 billion across 5 years, with a median of -$392.1 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings sank 146877.19% in 2022, then soared 99.87% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$489.5 million in 2021, then soared by 96.2% to -$18.6 million in 2022, then surged by 36.14% to -$11.9 million in 2023, then tumbled by 11320.41% to -$1.4 billion in 2024, then jumped by 99.87% to -$1.8 million in 2025.
- The last three Retained Earnings figures came in at -$1.8 million (Q4 2025), -$1.4 billion (Q4 2024), and -$1.3 billion (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -1.87 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -4.41 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.81 Mn |
| Dec 31, 2024 | -1.36 Bn |
| Sep 30, 2024 | -1.29 Bn |
| Jun 30, 2024 | -1.24 Bn |
| Dec 31, 2023 | -11.88 Mn |
| Sep 30, 2023 | -1.08 Bn |
| Jun 30, 2023 | -985.18 Mn |
| Dec 31, 2022 | -18.59 Mn |
| Sep 30, 2022 | -392.06 Mn |
| Jun 30, 2022 | -338.71 Mn |
| Mar 31, 2022 | -311.38 Bn |
| Dec 31, 2021 | -489.46 Mn |
| Sep 30, 2021 | -275.61 Mn |
| Jun 30, 2021 | -219.10 Mn |
| Mar 31, 2021 | -211.86 Mn |
| Dec 31, 2020 | -190.07 Mn |
| Sep 30, 2020 | -159.37 Mn |
| Dec 31, 2019 | -132.91 Mn |